Stable immunogen based on inner domain of hiv-1 gp120 for inducing immunity against hiv
AssigneeUniversity of Maryland, Baltimore
InventorsMarzena PAZGIER, George LEWIS, William TOLBERT, Neelakshi GOHAIN
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Maryland, Baltimore
InventorsMarzena PAZGIER, George LEWIS, William TOLBERT, Neelakshi GOHAIN
Estimating the term…
Stable immunogens comprising portions of the inner domain (ID) of the Human Immunodeficiency Virus (HIV-1) gp120 protein are provided. These ID immunogens selectively present the gp120 C1/C2 region in its CD4-bound state within a minimal structure. These ID immunogens can be used to vaccinate subjects against infection with HIV, the causative agent of Acquired Immunodeficiency Syndrome (AIDS). The immunogens can also be used as targets in screening to identify small molecule or peptide inhibitors that block HIV-1 viral entry and attachment steps, and as probes for identifying gp120 C1/C2 region-specific antibodies.
A HIV-1 gp120 inner domain (ID) immunogen, where the ID immunogen comprises:
A HIV-1 gp120 ID immunogen comprising an amino acid sequence set forth in any one of SEQ ID NOs:3-54 or a variant thereof having at least about 95% sequence identity with the immunogen over the entire length of the immunogen sequence.
14-23. (canceled)
Dependencies are inferred from the claim text.